Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

NCT02631057 · clinicaltrials.gov ↗

COMPLETED

Status

4313

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Dabigatran
DRUG: Warfarin

Sponsor

Boehringer Ingelheim